Vastus pöördumisele







PP Notice No. 1/2026
24 February 2026



FEEDBACK FORM
on cannabidiol (CBD)



To proceed, please identify yourself:

Country: Estonia

Agency: State Agency of Medicines; Nooruse 1, Tartu, 50411, Eesti

Name: Triinu Margens

E-mail: [email protected]















COUNTRY: ESTONIA

To the extent possible, kindly respond to the following questions:

National regulatory framework

1) Is cannabidiol (CBD) controlled in your country?
Yes ☒ No ☐ Unknown ☐

If yes, provide information about the nature of control (as drug precursor, …) and provide details of the law(s) regulating operators dealing in the substance.

CBD as a substance is not included in the list of narcotic and psychotropic substances. Nor does the substance have a psychotropic effect. However, all processed products of cannabis (except varieties included in the European Union’s Common Catalogue of Varieties of Agricultural Plant Species with a tetrahydrocannabinol content not exceeding 0.3%) are included in this list (hashish, marijuana, resin, extracts, tinctures, etc.). If CBD has been obtained from narcotic cannabis through extraction, CBD is also considered a narcotic substance.
CBD may not be used in cosmetic products if its THC content exceeds 0.3%. In cosmetic products, extracts of the cannabis plant and cannabis leaves may not be used if they have been obtained from a plant together with its flowering or fruiting tops.
Extracts obtained from the flowers and leaves of hemp (i.e. CBD and other cannabinoids) cannot be marketed as food (including food supplements) because they have not received a novel food permission from the European Commission. As long as CBD is a prohibited novel food in the EU, CBD can be produced as a novel food in Estonia only if the product/food raw material is marketed directly to a third country where its use is permitted.
https://www.riigiteataja.ee/en/eli/530092025003/consolide
https://www.riigiteataja.ee/en/eli/530092025003/consolide
https://www.riigiteataja.ee/aktilisa/1200/2202/6006/SOM_m2_lisa1.pdf#


2) Kindly provide the details of agency(ies) responsible for control of CBD (this would also help to register the agency for use of PEN Online Light).

Agricultural Registers And Information Board
Agriculture And Food Board
Estonian Police and Border Guard Board
Estonian Tax and Customs Board
State Agency of Medicines

Operators and Uses

3) To the extent possible, kindly provide details of the end-use(s) of CBD in your country and the estimated needs for each end-use.

the extraction of CBD oil from hemp is only possible for medical, scientific or crime prevention purposes.

4) To the extent available, kindly provide an indication of the number of companies dealing with CBD in any of the following ways:


Number
Quantity (kg)
Total number of companies dealing with CBD in any way
0
0
Of the total number, indicate:


• Number of companies manufacturing CBD (and the amount manufactured)
0
0
• Number of companies importing or exporting CBD
0
0
• Number of companies trading CBD domestically
0
0
• Number of end-using companies
0
0

Use of CBD in clandestine manufacturing

5) Kindly provide any evidence or intelligence (even if preliminary) related to the use of CBD for the illicit manufacture of THC, as well as synthetic and semi-synthetic cannabinoids (e.g., HHC, THCP, HHC-O, and other modified structures).

We don’t have information.

6) Any other comments you wish to make

Click or tap here to enter text.